Your SlideShare is downloading. ×
  • Like
Suppy chain management of pharma
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×

Now you can save presentations on your phone or tablet

Available for both IPhone and Android

Text the download link to your phone

Standard text messaging rates apply

Suppy chain management of pharma

  • 2,328 views
Published

PFIZER

PFIZER

Published in Business
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
No Downloads

Views

Total Views
2,328
On SlideShare
0
From Embeds
0
Number of Embeds
0

Actions

Shares
Downloads
200
Comments
0
Likes
1

Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
    No notes for slide

Transcript

  • 1. Supply Chain Management Of Pharmaceuticals“Working together for healthier world”
  • 2. Introduction of Pfizer• Pfizer, Inc. is an American multinational pharmaceutical• It is the worlds largest pharmaceutical company by revenues• Type:Public• Traded as: NYSE: PFE Dow Jones Component S&P 500 Component• Industry :Pharmaceutical• Founded :1849• Headquarters :Cooperate New York, United States research in Groton, Connecticut, United States• Area served :Worldwide• Key people :Ian Read• Revenue :US$ 67.42 billion (2011)• Employees :103,700 (2011)• Acquisitions: Warner–Lambert in 2000, Pharmacia in 2003 and Wyeth in 2009, the latter acquired for US$68 billion• Subsidiaries: Agouron Pharmaceuticals, G. D. Searle & Company, Greenstone, Parke-Davis, Pfizer UK, Warner Lambert, Wyeth• Products: Lipitor (atorvastatin),Lyrica (pregabalin); Diflucan (fluconazole), Zithromax (azithromycin), Viagra (sildenafil,) Celebrex (celecoxib)
  • 3. Pfizer in India• Pfizer Limited (India) has a turnover of US$ 184.96 million (March 2012)• One of the highest spenders in pharmaceutical R&D globally, Pfizer has made clinical research investments of US$ 1.18 million (March 2012) in India• The company was awarded the FICCI SEDF (Socio Economic Development Foundation) Certificate of Commendation for its social responsibility efforts• Pfizer has won several awards including that for the multinational pharmaceutical company of the year and the most respected MNCAbout our products• Six Pfizer brands feature among the Top 100 pharmaceutical brands in India• Two of Pfizer Indias brands -- Corex (Cough Formulation) and Becosules (Multivitamin) -- continue to rank among the Top 15 pharmaceutical drug brands• Pfizer has won the Golden Peacock Innovative Product for Magnex (Sulperazon)• Becosules has won the Most Trusted Brand AwardLocation & People• Headquartered in Mumbai• Over 3,000 colleagues• State-of-the-art manufacturing facility at Thane, Maharashtra
  • 4. An overview ofPharmaceuticalIndustry
  • 5. According to industry statistics, the pharmaceuticals market remains committed to recoverydespite the global economic slowdown, with a compound annual growth rate (CAGR) of 5-8%forecast for 2012-2015. This trend is supported by a consistent spending in R&D, about 18% ofrevenue or $68 billion in 2011, and an ever stronger focus on supply chain management.Pharmaceutical chemical spending approaches $100 billion and contract manufacturingcontinues its double digit growth (CAGR 11%) exceeding $25 billion/year (Figure 1). Supply chain management seems to be on the forefront of executives minds today, together with R&D productivity, cost cutting and M&A Pharmaceutical companies seek to adopt operational models from other industries with tighter margins and stealthier (Six-Sigma) performance
  • 6. ISSUSES
  • 7. What is Supply Chain Concept?"It is the strategic management of activities involved in the acquisition and conversion of materials to finished products delivered to the customer“ Supplier Customer Material Flow Information Flow Management Management Schedule/ Conversion Stock Delivery Resources Deployment
  • 8. Flow of Raw Material Till its User
  • 9. Flow of FINISHED PRODUCT to end users
  • 10. Inventory management
  • 11. Transportation management in pharmaceutical Industry
  • 12. PROBLEM2:DETERMINE THE OPTIMUM SOLUTION FOR THE COMPANY OF TRASPOTATION PROBLEM(USING NWCM AND MODI METHOD) WAREHOUSE CAPACITY W1 W2 W3 F1 8 8 15 120FACTORY F2 15 10 17 80 3 9 10 80 F3REQUIREMENT 150 80 50
  • 13. OPTIMUM SOLUTIONF1 W1 8*120 =960F1 W2 8*E = _F2 W2 10*80 =800F3 W1 3*30= 90F3 W3 10*50 =500 2,350 RS
  • 14. strengthState-of-the-art infrastructure Variety of formats supporting each other Better understanding of Indian suppliersHuge financial supportSystematic collection of data from supplier toretailer
  • 15. weakness
  • 16. opportunity• Growing pharmaceutical sector in india• Growing patient awareness• Implementation of better and organized government rule for inventory control and management of narcotic drugs etc• Inclination towards branded drugs and company• Better transportation and third party support
  • 17. Threat Key challenges related to drug supply chain are management of drug expiration, drug returns / recalls, counterfeit drugs and others.The drug recall process is complex and expensive, where all to be recall products need to be tracked and then shipped back Evolution of new companies at a very fast rate which is capturing the market share also increasing the chances of counterfeit drugs etc Illegal smuggling…. Government policies
  • 18. Strategies & ActivitiesCreate a Sustainable Drug Procurement and Supply Chain ManagementStrengthen:-MIS Division:new regulations like ePedigree and new technologies like EPC/RFID & 2D Barcodes are introducedFinance DivisionProcurement/Distribution Division
  • 19. Governments efforts• Strengthening Supply Chain ManagementIt has been proposed to establish a structured supply chain management system with a Logistic Manager at both State and District level ensuring the distribution system to flow in top to bottom approach• Strengthening Procurement SystemIn order to ensure hassle free procurement, the State proposes to create a Procurement Society To make the process even faster, it suggests decentralising small purchases at the District Level and positioning a procurement specialist at the zonal level.
  • 20. Conclusion• Review, Monitor and Validate• Strengthening Drug Procurement and Supply Chain Management• Strengthening Distribution Division• Additional Drug Requirement to meet Unforeseen Situations